StockData
Accuray Inc logo

Accuray Inc (ARAY) company profile

ARAYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 2/30
$2.44−0.11 (-4.31%)

Close on Nov 17, 2026Market cap $291.43MP/E –Yield –

About Accuray

Surgical & Medical Instruments & Apparatus, SIC 3841

Accuray Incorporated develops, manufactures, sells, and supports radiation therapy solutions, including treatment delivery, planning, imaging, and data management systems. Its core offerings feature the CyberKnife robotic platform and helical systems such as Accuray Stellar, Radixact, Accuray Helix, and Tomo C. The company also provides integrated software solutions, such as the Accuray Precision Treatment Planning System and iDMS Data Management System, alongside professional services like customer support, installation, and training. Accuray serves clinicians, hospitals, cancer centers, and healthcare providers, with its equipment utilized by radiation oncologists and neurosurgeons to treat cancerous and benign tumors and selected functional disorders.

Accuray operates regional offices outside the United States in Morges, Switzerland; Hong Kong, China; Shanghai, China; and Tokyo, Japan. The company maintains direct sales personnel in most of Western Europe, Canada, Japan, India, and Korea, while utilizing distributors across selected markets in Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Accuray maintains its principal United States office in Madison, Wisconsin.

Summary of the business section of Accuray's latest annual report, written by StockData.

Company profile

Company

Legal name
Accuray Inc
Founded
1990
Headquarters
Madison, WI
Address
1240 Deming Way 53717
Phone
(608) 824-2800
Employees
809, Jun 30, 2026
Industry
Surgical & Medical Instruments & Apparatus
Incorporated in
Delaware
Fiscal year ends
June 30
Auditor
GRANT THORNTON LLP, San Jose, California

Stock & identifiers

Ticker
ARAY
Exchange
Nasdaq
IPO date
Feb 8, 2007
Shares outstanding
119M, Aug 21, 2026
Public float
$86.94M, Dec 31, 2025
Filer category
Accelerated filer<br>Smaller reporting company
SEC CIK
1138723
CUSIP
004397105
ISIN
US0043971052
FIGI
BBG000QNRY51
Share class FIGI
BBG001SFHKJ0
LEI
549300G28LY4TZKZJG51
EIN
20-8370041

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Neve Stephen R. LaCEO, Director232,499
Michael John MurphyVP, Corporate Controller50,998
Ali PervaizSVP Chief Financial Officer366,259
Paul Michael MieleSVP, Chief Commercial Officer–
Sandeep ChalkeSVP, Chief Commercial Officer419,806
Leonel PeraltaSVP, Chief Operations Officer54,754
Suzanne C. WinterPresident and CEO1,200,047
Michael HogeSenior VP Global Operations357,431
Jesse ChewChief Legal Officer326,824
Steven F. MayerDirector40,055
Chan GalbatoDirector2,665
Joseph E. WhittersDirector18,106
Mika NishimuraDirector6,731
James M. HindmanDirector8,785
Richard A. MeierDirector–
Byron C. ScottDirector162,727
Beverly A. HussDirector243,965
Grand Anne Bryce LeDirector259,499
Robert KillDirector262,809

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2026
Steve La Neve
$5.23M$1.89M$737.60K$7–
FY2026
Suzanne Winter
$1.11M-$2.62M$737.60K$7–
FY2025
Sandeep Chalke
$1.20M$602.27K$1.23M$35–
FY2025
Suzanne Winter
$3.04M$1.20M$1.23M$35–
FY2024$3.52M-$125.70K$1.17M$47–
FY2023$2.64M$4.50M$1.14M$197–

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2026

Summary compensation table from the latest proxy statement

ExecutiveSalaryBonusStock awardsOtherTotalvs. prior year
Steve La Neve
President and Chief Executive Officer
$525.00K$262.50K$4.26M$63.22K$5.11M–
Ali Pervaiz
Senior Vice President, Chief Financial Officer
$452.33K–$131.26K$5.44K$589.03K-46%
Paul Miele
Senior Vice President, Chief Commercial Officer
$110.89K$87.00K$491.92K$4.25K$694.06K–
Suzanne Winter
Former President and Chief Executive Officer
$314.42K––$800.00K$1.11M-63%
Sandeep Chalke
Former Senior Vice President, Chief Commercial Officer
$346.02K–$118.80K$464.90K$929.72K-22%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
Feb 8, 2007
Offer price
$18.00
Securities offered
16,000,000
Gross proceeds
$288.00M
Exchange
Nasdaq
First trading day
Feb 8, 2007
First-day close
$28.47+58.2%
Lock-up ends (est.)
Aug 7, 2007

“Per share Total Public Offering Price $ 18.00 $ 288,000,000 Underwriting Discounts and Commissions $ 1.26 $ 20,160,000 Proceeds, Before Expenses, to Accuray Incorporated $ 16.74 $ 167,400,000 Proceeds, Before Expenses, to the Selling Stockholders $ 16.74 $ 100,440,000 The underwriters have a 30-day option to purcha”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“As of June 30, 2026, we had 809 employees, including 392 employees employed outside of the United States.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?